APO Research, Inc.

APO RESEARCH · REPORT

Digital Therapeutics Platforms

Selected research

Industry Growth & Trends

Global Digital Therapeutics Platforms Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Digital Therapeutics Platforms market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Digital Therapeutics Platforms is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Digital Therapeutics Platforms market include Akili Interactive, DarioHealth, Teladoc Health, Voluntis, Sidekick Health, WellDoc, Talkspace, CogniFit and Tata Elxsi, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Digital Therapeutics Platforms market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Digital Therapeutics Platforms market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Digital Therapeutics Platforms market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Digital Therapeutics Platforms.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Digital Therapeutics Platforms market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Digital Therapeutics Platforms Market by Company

Akili Interactive

DarioHealth

Teladoc Health

Voluntis

Sidekick Health

WellDoc

Talkspace

CogniFit

Tata Elxsi

Mahalo Health

2Morrow

Omada Health

Click Therapeutics

Orexo

ResMed

Virta Health

Bifourmis

SilverCloud (Amwell)

Noom

Big Health

Kaia Health

Cognoa

Headspace Health

CureApp

Calm Health

Riva Health

Sweetch-Health

Lark Health

Vida Health

Mahana Therapeutics

Blue Note Therapeutics

Lyra Health

Modern Health

Canary Health

Virgin Pulse

Slanhealth

Best Covered

Dami and Xiaomi

WeiMai

Jianhai Tech

Digital Therapeutics Platforms Segment by Type

Chronic Disease Digital Therapeutics

Psychiatric Disorders Digital Therapeutics

Quit Smoking Digital Therapeutics

Sleep Disorders and Respiratory Diseases Digital Therapeutics

Others

Digital Therapeutics Platforms Segment by Application

Enterprise

Personal

Digital Therapeutics Platforms Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Digital Therapeutics Platforms market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Digital Therapeutics Platforms and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Digital Therapeutics Platforms.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Digital Therapeutics Platforms companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Digital Therapeutics Platforms Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Digital Therapeutics Platforms Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Digital Therapeutics Platforms Market Share by Region (2021-2026) Table 4. Global Digital Therapeutics Platforms Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Digital Therapeutics Platforms Market Share by Region (2027-2032) Table 6. Global Digital Therapeutics Platforms Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Digital Therapeutics Platforms Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Digital Therapeutics Platforms Market Size Share by Type (2021-2026) Table 9. Global Digital Therapeutics Platforms Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Digital Therapeutics Platforms Market Size Share Forecasted by Type (2027-2032) Table 11. North America Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Digital Therapeutics Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Digital Therapeutics Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Digital Therapeutics Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Digital Therapeutics Platforms Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Digital Therapeutics Platforms Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Digital Therapeutics Platforms Market Size Share by Application (2021-2026) Table 24. Global Digital Therapeutics Platforms Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Digital Therapeutics Platforms Market Size Share Forecasted by Application (2027-2032) Table 26. North America Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Digital Therapeutics Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Digital Therapeutics Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Digital Therapeutics Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Digital Therapeutics Platforms Industry Trends Table 37. Digital Therapeutics Platforms Industry Drivers Table 38. Digital Therapeutics Platforms Industry Opportunities and Challenges Table 39. Digital Therapeutics Platforms Industry Restraints Table 40. Global Digital Therapeutics Platforms Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Digital Therapeutics Platforms Revenue Market Share by Company (2021-2026) Table 42. Global Digital Therapeutics Platforms Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Digital Therapeutics Platforms Key Company Headquarters & Area Served Table 44. Global Digital Therapeutics Platforms Company, Product Type & Application Table 45. Global Digital Therapeutics Platforms Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Digital Therapeutics Platforms by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Akili Interactive Company Information Table 49. Akili Interactive Business Overview Table 50. Akili Interactive Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Akili Interactive Digital Therapeutics Platforms Product Portfolio Table 52. Akili Interactive Recent Development Table 53. DarioHealth Company Information Table 54. DarioHealth Business Overview Table 55. DarioHealth Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. DarioHealth Digital Therapeutics Platforms Product Portfolio Table 57. DarioHealth Recent Development Table 58. Teladoc Health Company Information Table 59. Teladoc Health Business Overview Table 60. Teladoc Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Teladoc Health Digital Therapeutics Platforms Product Portfolio Table 62. Teladoc Health Recent Development Table 63. Voluntis Company Information Table 64. Voluntis Business Overview Table 65. Voluntis Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Voluntis Digital Therapeutics Platforms Product Portfolio Table 67. Voluntis Recent Development Table 68. Sidekick Health Company Information Table 69. Sidekick Health Business Overview Table 70. Sidekick Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Sidekick Health Digital Therapeutics Platforms Product Portfolio Table 72. Sidekick Health Recent Development Table 73. WellDoc Company Information Table 74. WellDoc Business Overview Table 75. WellDoc Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. WellDoc Digital Therapeutics Platforms Product Portfolio Table 77. WellDoc Recent Development Table 78. Talkspace Company Information Table 79. Talkspace Business Overview Table 80. Talkspace Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Talkspace Digital Therapeutics Platforms Product Portfolio Table 82. Talkspace Recent Development Table 83. CogniFit Company Information Table 84. CogniFit Business Overview Table 85. CogniFit Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. CogniFit Digital Therapeutics Platforms Product Portfolio Table 87. CogniFit Recent Development Table 88. Tata Elxsi Company Information Table 89. Tata Elxsi Business Overview Table 90. Tata Elxsi Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Tata Elxsi Digital Therapeutics Platforms Product Portfolio Table 92. Tata Elxsi Recent Development Table 93. Mahalo Health Company Information Table 94. Mahalo Health Business Overview Table 95. Mahalo Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Mahalo Health Digital Therapeutics Platforms Product Portfolio Table 97. Mahalo Health Recent Development Table 98. 2Morrow Company Information Table 99. 2Morrow Business Overview Table 100. 2Morrow Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. 2Morrow Digital Therapeutics Platforms Product Portfolio Table 102. 2Morrow Recent Development Table 103. Omada Health Company Information Table 104. Omada Health Business Overview Table 105. Omada Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Omada Health Digital Therapeutics Platforms Product Portfolio Table 107. Omada Health Recent Development Table 108. Click Therapeutics Company Information Table 109. Click Therapeutics Business Overview Table 110. Click Therapeutics Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Click Therapeutics Digital Therapeutics Platforms Product Portfolio Table 112. Click Therapeutics Recent Development Table 113. Orexo Company Information Table 114. Orexo Business Overview Table 115. Orexo Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Orexo Digital Therapeutics Platforms Product Portfolio Table 117. Orexo Recent Development Table 118. ResMed Company Information Table 119. ResMed Business Overview Table 120. ResMed Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. ResMed Digital Therapeutics Platforms Product Portfolio Table 122. ResMed Recent Development Table 123. Virta Health Company Information Table 124. Virta Health Business Overview Table 125. Virta Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Virta Health Digital Therapeutics Platforms Product Portfolio Table 127. Virta Health Recent Development Table 128. Bifourmis Company Information Table 129. Bifourmis Business Overview Table 130. Bifourmis Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Bifourmis Digital Therapeutics Platforms Product Portfolio Table 132. Bifourmis Recent Development Table 133. SilverCloud (Amwell) Company Information Table 134. SilverCloud (Amwell) Business Overview Table 135. SilverCloud (Amwell) Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio Table 137. SilverCloud (Amwell) Recent Development Table 138. Noom Company Information Table 139. Noom Business Overview Table 140. Noom Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Noom Digital Therapeutics Platforms Product Portfolio Table 142. Noom Recent Development Table 143. Big Health Company Information Table 144. Big Health Business Overview Table 145. Big Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Big Health Digital Therapeutics Platforms Product Portfolio Table 147. Big Health Recent Development Table 148. Kaia Health Company Information Table 149. Kaia Health Business Overview Table 150. Kaia Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 151. Kaia Health Digital Therapeutics Platforms Product Portfolio Table 152. Kaia Health Recent Development Table 153. Cognoa Company Information Table 154. Cognoa Business Overview Table 155. Cognoa Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 156. Cognoa Digital Therapeutics Platforms Product Portfolio Table 157. Cognoa Recent Development Table 158. Headspace Health Company Information Table 159. Headspace Health Business Overview Table 160. Headspace Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 161. Headspace Health Digital Therapeutics Platforms Product Portfolio Table 162. Headspace Health Recent Development Table 163. CureApp Company Information Table 164. CureApp Business Overview Table 165. CureApp Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 166. CureApp Digital Therapeutics Platforms Product Portfolio Table 167. CureApp Recent Development Table 168. Calm Health Company Information Table 169. Calm Health Business Overview Table 170. Calm Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 171. Calm Health Digital Therapeutics Platforms Product Portfolio Table 172. Calm Health Recent Development Table 173. Riva Health Company Information Table 174. Riva Health Business Overview Table 175. Riva Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 176. Riva Health Digital Therapeutics Platforms Product Portfolio Table 177. Riva Health Recent Development Table 178. Sweetch-Health Company Information Table 179. Sweetch-Health Business Overview Table 180. Sweetch-Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 181. Sweetch-Health Digital Therapeutics Platforms Product Portfolio Table 182. Sweetch-Health Recent Development Table 183. Lark Health Company Information Table 184. Lark Health Business Overview Table 185. Lark Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 186. Lark Health Digital Therapeutics Platforms Product Portfolio Table 187. Lark Health Recent Development Table 188. Vida Health Company Information Table 189. Vida Health Business Overview Table 190. Vida Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 191. Vida Health Digital Therapeutics Platforms Product Portfolio Table 192. Vida Health Recent Development Table 193. Mahana Therapeutics Company Information Table 194. Mahana Therapeutics Business Overview Table 195. Mahana Therapeutics Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 196. Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio Table 197. Mahana Therapeutics Recent Development Table 198. Blue Note Therapeutics Company Information Table 199. Blue Note Therapeutics Business Overview Table 200. Blue Note Therapeutics Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 201. Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio Table 202. Blue Note Therapeutics Recent Development Table 203. Lyra Health Company Information Table 204. Lyra Health Business Overview Table 205. Lyra Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 206. Lyra Health Digital Therapeutics Platforms Product Portfolio Table 207. Lyra Health Recent Development Table 208. Modern Health Company Information Table 209. Modern Health Business Overview Table 210. Modern Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 211. Modern Health Digital Therapeutics Platforms Product Portfolio Table 212. Modern Health Recent Development Table 213. Canary Health Company Information Table 214. Canary Health Business Overview Table 215. Canary Health Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 216. Canary Health Digital Therapeutics Platforms Product Portfolio Table 217. Canary Health Recent Development Table 218. Virgin Pulse Company Information Table 219. Virgin Pulse Business Overview Table 220. Virgin Pulse Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 221. Virgin Pulse Digital Therapeutics Platforms Product Portfolio Table 222. Virgin Pulse Recent Development Table 223. Slanhealth Company Information Table 224. Slanhealth Business Overview Table 225. Slanhealth Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 226. Slanhealth Digital Therapeutics Platforms Product Portfolio Table 227. Slanhealth Recent Development Table 228. Best Covered Company Information Table 229. Best Covered Business Overview Table 230. Best Covered Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 231. Best Covered Digital Therapeutics Platforms Product Portfolio Table 232. Best Covered Recent Development Table 233. Dami and Xiaomi Company Information Table 234. Dami and Xiaomi Business Overview Table 235. Dami and Xiaomi Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 236. Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio Table 237. Dami and Xiaomi Recent Development Table 238. WeiMai Company Information Table 239. WeiMai Business Overview Table 240. WeiMai Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 241. WeiMai Digital Therapeutics Platforms Product Portfolio Table 242. WeiMai Recent Development Table 243. Jianhai Tech Company Information Table 244. Jianhai Tech Business Overview Table 245. Jianhai Tech Digital Therapeutics Platforms Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 246. Jianhai Tech Digital Therapeutics Platforms Product Portfolio Table 247. Jianhai Tech Recent Development Table 248. North America Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 249. North America Digital Therapeutics Platforms Market Size by Country (2021-2026) & (US$ Million) Table 250. North America Digital Therapeutics Platforms Market Share by Country (2021-2026) Table 251. North America Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 252. North America Digital Therapeutics Platforms Market Share Forecast by Country (2027-2032) Table 253. Europe Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 254. Europe Digital Therapeutics Platforms Market Size by Country (2021-2026) & (US$ Million) Table 255. Europe Digital Therapeutics Platforms Market Share by Country (2021-2026) Table 256. Europe Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 257. Europe Digital Therapeutics Platforms Market Share Forecast by Country (2027-2032) Table 258. Asia-Pacific Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 259. Asia-Pacific Digital Therapeutics Platforms Market Size by Country (2021-2026) & (US$ Million) Table 260. Asia-Pacific Digital Therapeutics Platforms Market Share by Country (2021-2026) Table 261. Asia-Pacific Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 262. Asia-Pacific Digital Therapeutics Platforms Market Share Forecast by Country (2027-2032) Table 263. Latin America Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 264. Latin America Digital Therapeutics Platforms Market Size by Country (2021-2026) & (US$ Million) Table 265. Latin America Digital Therapeutics Platforms Market Share by Country (2021-2026) Table 266. Latin America Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 267. Latin America Digital Therapeutics Platforms Market Share Forecast by Country (2027-2032) Table 268. Middle East & Africa Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 269. Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021-2026) & (US$ Million) Table 270. Middle East & Africa Digital Therapeutics Platforms Market Share by Country (2021-2026) Table 271. Middle East & Africa Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032) & (US$ Million) Table 272. Middle East & Africa Digital Therapeutics Platforms Market Share Forecast by Country (2027-2032) Table 273. Research Programs/Design for This Report Table 274. Authors List of This Report Table 275. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Digital Therapeutics Platforms Product Image Figure 3. Global Digital Therapeutics Platforms Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Digital Therapeutics Platforms Market Size (2021-2032) & (US$ Million) Figure 5. Global Digital Therapeutics Platforms Market Share by Region: 2025 VS 2032 Figure 6. Global Digital Therapeutics Platforms Market Share by Region (2021-2032) Figure 7. North America Digital Therapeutics Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Digital Therapeutics Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Digital Therapeutics Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Digital Therapeutics Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Digital Therapeutics Platforms Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Chronic Disease Digital Therapeutics Image Figure 13. Global Chronic Disease Digital Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Psychiatric Disorders Digital Therapeutics Image Figure 15. Global Psychiatric Disorders Digital Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Quit Smoking Digital Therapeutics Image Figure 17. Global Quit Smoking Digital Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Sleep Disorders and Respiratory Diseases Digital Therapeutics Image Figure 19. Global Sleep Disorders and Respiratory Diseases Digital Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Others Image Figure 21. Global Others Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Global Digital Therapeutics Platforms Market Size Overview by Type (2021-2032) & (US$ Million) Figure 23. Global Digital Therapeutics Platforms Market Share by Type 2025 VS 2032 Figure 24. North America Digital Therapeutics Platforms Market Size Share by Type (2021-2032) Figure 25. Europe Digital Therapeutics Platforms Market Size Share by Type (2021-2032) Figure 26. Asia-Pacific Digital Therapeutics Platforms Market Size Share by Type (2021-2032) Figure 27. Latin America Digital Therapeutics Platforms Market Size Share by Type (2021-2032) Figure 28. Middle East and Africa Digital Therapeutics Platforms Market Size Share by Type (2021-2032) Figure 29. Enterprise Image Figure 30. Global Enterprise Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Personal Image Figure 32. Global Personal Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Digital Therapeutics Platforms Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Digital Therapeutics Platforms Market Share by Application 2025 VS 2032 Figure 35. North America Digital Therapeutics Platforms Market Size Share by Application (2021-2032) Figure 36. Europe Digital Therapeutics Platforms Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Digital Therapeutics Platforms Market Size Share by Application (2021-2032) Figure 38. Latin America Digital Therapeutics Platforms Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Digital Therapeutics Platforms Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Digital Therapeutics Platforms Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Digital Therapeutics Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Digital Therapeutics Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 45. Europe Digital Therapeutics Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Digital Therapeutics Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 48. Asia-Pacific Digital Therapeutics Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Digital Therapeutics Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 51. Latin America Digital Therapeutics Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Digital Therapeutics Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 54. Middle East & Africa Digital Therapeutics Platforms Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Digital Therapeutics Platforms Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Digital Therapeutics Platforms Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • Chronic Disease Digital Therapeutics
  • Psychiatric Disorders Digital Therapeutics
  • Quit Smoking Digital Therapeutics
  • Sleep Disorders and Respiratory Diseases Digital Therapeutics
  • Others
Applications
  • Enterprise
  • Personal
Companies covered
  • Akili Interactive
  • DarioHealth
  • Teladoc Health
  • Voluntis
  • Sidekick Health
  • WellDoc
  • Talkspace
  • CogniFit
  • Tata Elxsi
  • Mahalo Health
  • 2Morrow
  • Omada Health
  • Click Therapeutics
  • Orexo
  • ResMed
  • Virta Health
  • Bifourmis
  • SilverCloud (Amwell)
  • Noom
  • Big Health
  • Kaia Health
  • Cognoa
  • Headspace Health
  • CureApp
  • Calm Health
  • Riva Health
  • Sweetch-Health
  • Lark Health
  • Vida Health
  • Mahana Therapeutics
  • Blue Note Therapeutics
  • Lyra Health
  • Modern Health
  • Canary Health
  • Virgin Pulse
  • Slanhealth
  • Best Covered
  • Dami and Xiaomi
  • WeiMai
  • Jianhai Tech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Digital Therapeutics Platforms Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Digital Therapeutics Platforms Market Size by Region (2021-2032)
  5. 1.4.1 Global Digital Therapeutics Platforms Market Size by Region (2021-2026)
  6. 1.4.2 Global Digital Therapeutics Platforms Market Size by Region (2027-2032)
  7. 1.5 Key Regions Digital Therapeutics Platforms Market Size (2021-2032)
  8. 1.5.1 North America Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Digital Therapeutics Platforms Market Size Growth Rate (2021-2032)
2 Digital Therapeutics Platforms Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Chronic Disease Digital Therapeutics
  3. 2.1.2 Psychiatric Disorders Digital Therapeutics
  4. 2.1.3 Quit Smoking Digital Therapeutics
  5. 2.1.4 Sleep Disorders and Respiratory Diseases Digital Therapeutics
  6. 2.1.5 Others
  7. 2.2 Global Digital Therapeutics Platforms Market Size by Type
  8. 2.2.1 Global Digital Therapeutics Platforms Market Size Overview by Type (2021-2032)
  9. 2.2.2 Global Digital Therapeutics Platforms Historic Market Size Review by Type (2021-2026)
  10. 2.2.3 Global Digital Therapeutics Platforms Market Size Forecasted by Type (2027-2032)
  11. 2.3 Global Digital Therapeutics Platforms Market Size by Regions
  12. 2.3.1 North America Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
  13. 2.3.2 Europe Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
  14. 2.3.3 Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
  15. 2.3.4 South America Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
  16. 2.3.5 Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Type (2021-2026)
3 Digital Therapeutics Platforms Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Enterprise
  3. 3.1.2 Personal
  4. 3.2 Global Digital Therapeutics Platforms Market Size by Application
  5. 3.2.1 Global Digital Therapeutics Platforms Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Digital Therapeutics Platforms Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Digital Therapeutics Platforms Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Digital Therapeutics Platforms Market Size by Regions
  9. 3.3.1 North America Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Digital Therapeutics Platforms Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Digital Therapeutics Platforms Industry Trends
  2. 4.2 Digital Therapeutics Platforms Industry Drivers
  3. 4.3 Digital Therapeutics Platforms Industry Opportunities and Challenges
  4. 4.4 Digital Therapeutics Platforms Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Digital Therapeutics Platforms Revenue (2021-2026)
  2. 5.2 Global Digital Therapeutics Platforms Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Digital Therapeutics Platforms Key Company Headquarters & Area Served
  4. 5.4 Global Digital Therapeutics Platforms Company, Product Type & Application
  5. 5.5 Global Digital Therapeutics Platforms Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Digital Therapeutics Platforms Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Digital Therapeutics Platforms Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Digital Therapeutics Platforms Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Akili Interactive
  2. 6.1.1 Akili Interactive Company Information
  3. 6.1.2 Akili Interactive Business Overview
  4. 6.1.3 Akili Interactive Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Akili Interactive Digital Therapeutics Platforms Product Portfolio
  6. 6.1.5 Akili Interactive Recent Developments
  7. 6.2 DarioHealth
  8. 6.2.1 DarioHealth Company Information
  9. 6.2.2 DarioHealth Business Overview
  10. 6.2.3 DarioHealth Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 DarioHealth Digital Therapeutics Platforms Product Portfolio
  12. 6.2.5 DarioHealth Recent Developments
  13. 6.3 Teladoc Health
  14. 6.3.1 Teladoc Health Company Information
  15. 6.3.2 Teladoc Health Business Overview
  16. 6.3.3 Teladoc Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Teladoc Health Digital Therapeutics Platforms Product Portfolio
  18. 6.3.5 Teladoc Health Recent Developments
  19. 6.4 Voluntis
  20. 6.4.1 Voluntis Company Information
  21. 6.4.2 Voluntis Business Overview
  22. 6.4.3 Voluntis Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Voluntis Digital Therapeutics Platforms Product Portfolio
  24. 6.4.5 Voluntis Recent Developments
  25. 6.5 Sidekick Health
  26. 6.5.1 Sidekick Health Company Information
  27. 6.5.2 Sidekick Health Business Overview
  28. 6.5.3 Sidekick Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Sidekick Health Digital Therapeutics Platforms Product Portfolio
  30. 6.5.5 Sidekick Health Recent Developments
  31. 6.6 WellDoc
  32. 6.6.1 WellDoc Company Information
  33. 6.6.2 WellDoc Business Overview
  34. 6.6.3 WellDoc Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 WellDoc Digital Therapeutics Platforms Product Portfolio
  36. 6.6.5 WellDoc Recent Developments
  37. 6.7 Talkspace
  38. 6.7.1 Talkspace Company Information
  39. 6.7.2 Talkspace Business Overview
  40. 6.7.3 Talkspace Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Talkspace Digital Therapeutics Platforms Product Portfolio
  42. 6.7.5 Talkspace Recent Developments
  43. 6.8 CogniFit
  44. 6.8.1 CogniFit Company Information
  45. 6.8.2 CogniFit Business Overview
  46. 6.8.3 CogniFit Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 CogniFit Digital Therapeutics Platforms Product Portfolio
  48. 6.8.5 CogniFit Recent Developments
  49. 6.9 Tata Elxsi
  50. 6.9.1 Tata Elxsi Company Information
  51. 6.9.2 Tata Elxsi Business Overview
  52. 6.9.3 Tata Elxsi Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Tata Elxsi Digital Therapeutics Platforms Product Portfolio
  54. 6.9.5 Tata Elxsi Recent Developments
  55. 6.10 Mahalo Health
  56. 6.10.1 Mahalo Health Company Information
  57. 6.10.2 Mahalo Health Business Overview
  58. 6.10.3 Mahalo Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Mahalo Health Digital Therapeutics Platforms Product Portfolio
  60. 6.10.5 Mahalo Health Recent Developments
  61. 6.11 2Morrow
  62. 6.11.1 2Morrow Company Information
  63. 6.11.2 2Morrow Business Overview
  64. 6.11.3 2Morrow Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 2Morrow Digital Therapeutics Platforms Product Portfolio
  66. 6.11.5 2Morrow Recent Developments
  67. 6.12 Omada Health
  68. 6.12.1 Omada Health Company Information
  69. 6.12.2 Omada Health Business Overview
  70. 6.12.3 Omada Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Omada Health Digital Therapeutics Platforms Product Portfolio
  72. 6.12.5 Omada Health Recent Developments
  73. 6.13 Click Therapeutics
  74. 6.13.1 Click Therapeutics Company Information
  75. 6.13.2 Click Therapeutics Business Overview
  76. 6.13.3 Click Therapeutics Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Click Therapeutics Digital Therapeutics Platforms Product Portfolio
  78. 6.13.5 Click Therapeutics Recent Developments
  79. 6.14 Orexo
  80. 6.14.1 Orexo Company Information
  81. 6.14.2 Orexo Business Overview
  82. 6.14.3 Orexo Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Orexo Digital Therapeutics Platforms Product Portfolio
  84. 6.14.5 Orexo Recent Developments
  85. 6.15 ResMed
  86. 6.15.1 ResMed Company Information
  87. 6.15.2 ResMed Business Overview
  88. 6.15.3 ResMed Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 ResMed Digital Therapeutics Platforms Product Portfolio
  90. 6.15.5 ResMed Recent Developments
  91. 6.16 Virta Health
  92. 6.16.1 Virta Health Company Information
  93. 6.16.2 Virta Health Business Overview
  94. 6.16.3 Virta Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Virta Health Digital Therapeutics Platforms Product Portfolio
  96. 6.16.5 Virta Health Recent Developments
  97. 6.17 Bifourmis
  98. 6.17.1 Bifourmis Company Information
  99. 6.17.2 Bifourmis Business Overview
  100. 6.17.3 Bifourmis Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Bifourmis Digital Therapeutics Platforms Product Portfolio
  102. 6.17.5 Bifourmis Recent Developments
  103. 6.18 SilverCloud (Amwell)
  104. 6.18.1 SilverCloud (Amwell) Company Information
  105. 6.18.2 SilverCloud (Amwell) Business Overview
  106. 6.18.3 SilverCloud (Amwell) Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 SilverCloud (Amwell) Digital Therapeutics Platforms Product Portfolio
  108. 6.18.5 SilverCloud (Amwell) Recent Developments
  109. 6.19 Noom
  110. 6.19.1 Noom Company Information
  111. 6.19.2 Noom Business Overview
  112. 6.19.3 Noom Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Noom Digital Therapeutics Platforms Product Portfolio
  114. 6.19.5 Noom Recent Developments
  115. 6.20 Big Health
  116. 6.20.1 Big Health Company Information
  117. 6.20.2 Big Health Business Overview
  118. 6.20.3 Big Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Big Health Digital Therapeutics Platforms Product Portfolio
  120. 6.20.5 Big Health Recent Developments
  121. 6.21 Kaia Health
  122. 6.21.1 Kaia Health Company Information
  123. 6.21.2 Kaia Health Business Overview
  124. 6.21.3 Kaia Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  125. 6.21.4 Kaia Health Digital Therapeutics Platforms Product Portfolio
  126. 6.21.5 Kaia Health Recent Developments
  127. 6.22 Cognoa
  128. 6.22.1 Cognoa Company Information
  129. 6.22.2 Cognoa Business Overview
  130. 6.22.3 Cognoa Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  131. 6.22.4 Cognoa Digital Therapeutics Platforms Product Portfolio
  132. 6.22.5 Cognoa Recent Developments
  133. 6.23 Headspace Health
  134. 6.23.1 Headspace Health Company Information
  135. 6.23.2 Headspace Health Business Overview
  136. 6.23.3 Headspace Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  137. 6.23.4 Headspace Health Digital Therapeutics Platforms Product Portfolio
  138. 6.23.5 Headspace Health Recent Developments
  139. 6.24 CureApp
  140. 6.24.1 CureApp Company Information
  141. 6.24.2 CureApp Business Overview
  142. 6.24.3 CureApp Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  143. 6.24.4 CureApp Digital Therapeutics Platforms Product Portfolio
  144. 6.24.5 CureApp Recent Developments
  145. 6.25 Calm Health
  146. 6.25.1 Calm Health Company Information
  147. 6.25.2 Calm Health Business Overview
  148. 6.25.3 Calm Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  149. 6.25.4 Calm Health Digital Therapeutics Platforms Product Portfolio
  150. 6.25.5 Calm Health Recent Developments
  151. 6.26 Riva Health
  152. 6.26.1 Riva Health Company Information
  153. 6.26.2 Riva Health Business Overview
  154. 6.26.3 Riva Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  155. 6.26.4 Riva Health Digital Therapeutics Platforms Product Portfolio
  156. 6.26.5 Riva Health Recent Developments
  157. 6.27 Sweetch-Health
  158. 6.27.1 Sweetch-Health Company Information
  159. 6.27.2 Sweetch-Health Business Overview
  160. 6.27.3 Sweetch-Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  161. 6.27.4 Sweetch-Health Digital Therapeutics Platforms Product Portfolio
  162. 6.27.5 Sweetch-Health Recent Developments
  163. 6.28 Lark Health
  164. 6.28.1 Lark Health Company Information
  165. 6.28.2 Lark Health Business Overview
  166. 6.28.3 Lark Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  167. 6.28.4 Lark Health Digital Therapeutics Platforms Product Portfolio
  168. 6.28.5 Lark Health Recent Developments
  169. 6.29 Vida Health
  170. 6.29.1 Vida Health Company Information
  171. 6.29.2 Vida Health Business Overview
  172. 6.29.3 Vida Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  173. 6.29.4 Vida Health Digital Therapeutics Platforms Product Portfolio
  174. 6.29.5 Vida Health Recent Developments
  175. 6.30 Mahana Therapeutics
  176. 6.30.1 Mahana Therapeutics Company Information
  177. 6.30.2 Mahana Therapeutics Business Overview
  178. 6.30.3 Mahana Therapeutics Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  179. 6.30.4 Mahana Therapeutics Digital Therapeutics Platforms Product Portfolio
  180. 6.30.5 Mahana Therapeutics Recent Developments
  181. 6.31 Blue Note Therapeutics
  182. 6.31.1 Blue Note Therapeutics Company Information
  183. 6.31.2 Blue Note Therapeutics Business Overview
  184. 6.31.3 Blue Note Therapeutics Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  185. 6.31.4 Blue Note Therapeutics Digital Therapeutics Platforms Product Portfolio
  186. 6.31.5 Blue Note Therapeutics Recent Developments
  187. 6.32 Lyra Health
  188. 6.32.1 Lyra Health Company Information
  189. 6.32.2 Lyra Health Business Overview
  190. 6.32.3 Lyra Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  191. 6.32.4 Lyra Health Digital Therapeutics Platforms Product Portfolio
  192. 6.32.5 Lyra Health Recent Developments
  193. 6.33 Modern Health
  194. 6.33.1 Modern Health Company Information
  195. 6.33.2 Modern Health Business Overview
  196. 6.33.3 Modern Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  197. 6.33.4 Modern Health Digital Therapeutics Platforms Product Portfolio
  198. 6.33.5 Modern Health Recent Developments
  199. 6.34 Canary Health
  200. 6.34.1 Canary Health Company Information
  201. 6.34.2 Canary Health Business Overview
  202. 6.34.3 Canary Health Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  203. 6.34.4 Canary Health Digital Therapeutics Platforms Product Portfolio
  204. 6.34.5 Canary Health Recent Developments
  205. 6.35 Virgin Pulse
  206. 6.35.1 Virgin Pulse Company Information
  207. 6.35.2 Virgin Pulse Business Overview
  208. 6.35.3 Virgin Pulse Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  209. 6.35.4 Virgin Pulse Digital Therapeutics Platforms Product Portfolio
  210. 6.35.5 Virgin Pulse Recent Developments
  211. 6.36 Slanhealth
  212. 6.36.1 Slanhealth Company Information
  213. 6.36.2 Slanhealth Business Overview
  214. 6.36.3 Slanhealth Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  215. 6.36.4 Slanhealth Digital Therapeutics Platforms Product Portfolio
  216. 6.36.5 Slanhealth Recent Developments
  217. 6.37 Best Covered
  218. 6.37.1 Best Covered Company Information
  219. 6.37.2 Best Covered Business Overview
  220. 6.37.3 Best Covered Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  221. 6.37.4 Best Covered Digital Therapeutics Platforms Product Portfolio
  222. 6.37.5 Best Covered Recent Developments
  223. 6.38 Dami and Xiaomi
  224. 6.38.1 Dami and Xiaomi Company Information
  225. 6.38.2 Dami and Xiaomi Business Overview
  226. 6.38.3 Dami and Xiaomi Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  227. 6.38.4 Dami and Xiaomi Digital Therapeutics Platforms Product Portfolio
  228. 6.38.5 Dami and Xiaomi Recent Developments
  229. 6.39 WeiMai
  230. 6.39.1 WeiMai Company Information
  231. 6.39.2 WeiMai Business Overview
  232. 6.39.3 WeiMai Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  233. 6.39.4 WeiMai Digital Therapeutics Platforms Product Portfolio
  234. 6.39.5 WeiMai Recent Developments
  235. 6.40 Jianhai Tech
  236. 6.40.1 Jianhai Tech Company Information
  237. 6.40.2 Jianhai Tech Business Overview
  238. 6.40.3 Jianhai Tech Digital Therapeutics Platforms Revenue, Global Share and Gross Margin (2021-2026)
  239. 6.40.4 Jianhai Tech Digital Therapeutics Platforms Product Portfolio
  240. 6.40.5 Jianhai Tech Recent Developments
7 North America
  1. 7.1 North America Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Digital Therapeutics Platforms Market Size by Country (2021-2026)
  3. 7.3 North America Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Digital Therapeutics Platforms Market Size by Country (2021-2026)
  3. 8.3 Europe Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Digital Therapeutics Platforms Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Digital Therapeutics Platforms Market Size by Country (2021-2026)
  3. 10.3 South America Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Digital Therapeutics Platforms Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Digital Therapeutics Platforms Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Digital Therapeutics Platforms Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.